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Circular dichroism (CD) measurements were carried out on a JASCO J-815 CD spectrometer. The polypeptides samples were prepared at concentrations of 0.40 mg/mL in water, and placed in a quartz cell with a pathlength of 0.10 cm prior to measurements.
Infrared spectra were recorded on a Perkin Elmer 100 serial FTIR spectrophotometer calibrated with polystyrene film. Lyophilization was conducted in a FreeZonelyophilizer (Labconco, Kansas City, MO, USA). HPLC analyses were performed on a Shimadzu CBM-20A system (Shimadzu, Kyoto, Japan) equipped with SPD20A PDA detector (190 nm-800 nm) and RF10Axl fluorescence detector, and an analytical C18 column (Shimadzu, 3 µm, 50*4.6 mm, Kyoto, Japan).
Synthesis of γ-(6-chlorohexyl)-L-glutamate (CH-L-Glu).
L-Glutamic acid (10.0 g, 68.0 mmol) and 6-chlorohexanol (15 mL, 112.4mmol) were mixed and stirred at 0 °C, followed by the dropwise addition of H2SO4 (4 mL). The reaction was allowed to warm up to the room temperature and kept stirred for 24 h. Saturated Na2CO3 solution was then added to adjust the pH value to 7. The resulting precipitate was collected by filtration and purified by recrystallization from isopropanol/H2O (1:1, v/v). Isopropanol was removed under vacuum and water was removed via lyophilization to obtain a white solid powder (6.92 g, yield: 38%). 1 H NMR (DMSO:DCl-D2O, 9:1, v/v): δ 3.91 (t, 2H, -CH2OOC-), 3 .82 (t, 1H, α-H), 3.52 (t, 2H, -CH2Cl), 2.53-2.32 (m, 2H, -CH2CH2COO-), 1.98 (m, 2H, -CH2CH2COO-), 1.64-1.17 (m, 8H, ClCH2(CH2)4CH2O-). S5 CH-DL-Glu was synthesized similarly using DL-glutamic acid as the starting material (Yield: 36 %). 1 H NMR (DMSO:DCl-D2O, 9:1, v/v): 3.91 (t, 2H, -CH2OOC-), 3 .82 (t, 1H, α-H), 3.52 (t, 2H, -CH2Cl), 2.53-2.32 (m, 2H, -CH2CH2COO-), 1.98 (m, 2H, -CH2CH2COO-), 1.64-1.17 (m, 8H, ClCH2(CH2)4CH2O-).
Synthesis of CH-L-Glu based N-carboxyanhydride (CH-L-Glu-NCA).
A round-bottomed flask (100 mL) was charged with CH-L-Glu (7.3 g, 27.4 mmol) and dried under vacuum for 2 h. Anhydrous tetrahydrofuran (THF, 60 mL) and phosgene (15wt% in toluene, 39.2 mL, 54.9mmol) were added successively with the protection of nitrogen. The mixture was stirred at 50 °C for 2 h. The solvent was removed under vacuum to yield an oily liquid. The product was purified by silica gel column chromatography using EtOAC/hexane (from 100 % to 60 % hexanes) as the eluent (6.6 g, yield: 83 %). 1 Synthesis of poly(γ-6-chlorohexyl-L-glutamate) (PCHLG). In a glovebox, CH-L-Glu NCA (100 mg, 0.34mmol) was dissolved in DMF (1.5 mL), followed by the addition of 85 µL or 136 µL HMDS (0.1 M) in DMF to obtain PCHLG40 and PCHLG28. The mixture was stirred at room temperature for 48 h. The polymer was then obtained by precipitation in cold methanol and dried under vacuum at 40 °C for 8 h (Yield: PCHLG40: 66 %, PCHLG28: 56%). 1 (http://spin.niddk.nih.gov/bax/nmrserver/pdbutil). An in-house code was used to graft the side chains to the backbone to synthesize the initial peptide structure. The peptide was prepared as a zwitterion, and the terminal benzimidazole groups' protonated, such that the peptide carries a net formal charge of (+20). The peptide was placed in a 9×9×9 nm cubic simulation box with periodic boundary conditions, and solvated by SPC water molecules (6) to a density of 1.0 g/cm 3 along with 20 Cl -counter ions such that the system carried no net charge. The size of the simulation box was specified such that with a 1.2 nm real-space cutoff each solvent molecule was able to interact with at most one periodic image of the peptide, even in its fully extended conformation.
Molecular dynamics simulations were conducted using the GROMACS 4.6 simulation S9 suite (7) . High-energy overlaps in the initial configuration were eliminated by steepest descent energy minimization to remove forces exceeding 1000 kJ/mol.nm. Simulations were performed in the NPT ensemble at 298 K and 1 bar, employing a Nosé-Hoover thermostat (8) and Parrinello-Rahman barostat (9) . Initial atom velocities were randomly assigned from a Maxwell distribution at 298 K. The equations of motion were numerically integrated using a leap-frog algorithm (10) with a 2 fs time step, and bond lengths fixed using the LINCS algorithm to improve efficiency (11) . Electrostatic interactions were treated using Particle Mesh Ewald (PME) with a real-space cutoff of 1.2 nm and a 0.12 nm Fourier grid spacing (12) . Lennard-Jones interactions were shifted smoothly to zero at a 1.2 nm, and Lorentz-Berthelot combining rules used to determine interaction parameters between unlike atoms (13). A 1.5 ns equilibration run was conducted, at which time the temperature, pressure, energy, and peptide radius of gyration had attained stable values. We then performed a 68 ns production run, harvesting snapshots of the system configuration for analysis every 5 ps. The peptide remained fully alpha-helical over the entire course of the simulation trajectory. We present in the Supplementary Information a movie of the simulation trajectory showing the dynamical evolution of the side chains around the α-helical core (Movie S1), and a 360° rotation around a representative peptide configuration (Movie S2).
Minimal inhibition concentration (MIC).
Gram-negative bacteria, DH5α (E. coli), The stability of polypeptide was tested in the MIC assay in different environments, including salts, serum, plasma, tear fluid, and mucin. 1 ×10 6 CFU/ml of E. coli DH5α and S. aureus ATCC12608 were treated with peptides, while different conditions were added to LB medium, and the final concentrations of physiological conditions were as follows: 150 mM NaCl, 1 mM MgCl2, 2.5mM CaCl2, 2% human serum, 5% FBS, 10%
FBS, 2% plasma, 5% plasma, 2% artificial tear (from Boss Safety Poducts) and 1 mg/mL mucin. After these treatments, the procedures were same as MIC assay described above.
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Killing kinetics. The killing kinetics and killing efficiency of PHLG-BIm were measured against the microbes by counting the colony forming units of live bacteria with agar plating. The bacteria were prepared using the same procedure described in the MIC measurement. The samples were treated with PHLG-BIm40 at MIC or double of the MIC and incubated at 37 °C under constant shaking (100 rpm). Samples were taken for a series of ten-fold dilutions, and plated out in LB agar plates at predetermined time intervals (1 h, 2 h, 8h and 24h). The plates were incubated over night at 37 °C and the bacteria were counted by CFU. The bacteria (DH5α, ATCC12608) were also incubated with PHLG-BIm40 at various concentrations without or with NaCl (150 mM), 2% human serum, 2% plasma, 2% artificial tear. The bacteria were prepared using the same procedure described in the MIC measurement. After 8 h incubation, Samples were taken for a series of ten-fold dilutions, and plated out in LB agar plates, and the bacteria were counted by CFU after overnight incubation at 37 °C.
Hemolytic assay. Fresh rabbit blood was obtained and subjected to 25-fold dilution with PBS buffer to reach a concentration of approximately 4% (in volume) of the blood cells.
300 μL of PBS solution containing a polymer at various concentrations was placed in a 1.5 mL microfuge tube, followed by the addition of an equal volume (300 μL) of red blood cell suspension. The mixture was incubated at 37 °C for 1 h to allow for the hemolysis process to take place. At the end of the incubation time, the non-hemolysed red blood cells were separated by centrifugation at 1000 rpm for 5 min. Aliquots (100 μL) of nm/590-800 nm).
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Liposome dye leakage assay. Calcein dye was dissolved in Tris buffer (pH = 7) to achieve a concentration of 40 mM. To a clean round-bottom flask, appropriate volumes of lipid stocks were added to make up 1 mL of CHCl3 (For 3:1 POPE
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine)/POPG
(1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt)) vesicles, POPE (130 µL, 25 mg/mL CHCl3) and POPG (115 µL, 10 mg/mL CHCl3) were used; For
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) vesicles, DOPC (100 µL, 25 mg/mL CHCl3) and POPC (1 mL, 10 mg/mL CHCl3) were used). The solvent was removed by a stream of nitrogen gas to obtain a thin lipid film, which was then hydrated by 1 mL of calcein solution. The mixture was left to stir for 1 h, after which it was subjected to 10 freeze−thaw cycles (using dry ice/acetone to freeze and warm water to thaw). The suspension was extruded 20 times through a polycarbonate membrane with 400 nm pore diameter. The excess dye was removed using Sephadex G-50 column as the eluent. Time (min) Figure S8 . The stability of LL-37 when incubated with trypsin or pronase, or elastrase from P. aeuginosa, or elastrase from human leukocytes for 8 h. With PHDLG-BIm40 (1.6 µM) 6.9 (1.5) 6.9 (1.1) 6.9 (1.1)
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With PHLG-BIm40 (0. Movie S1. Movie of the 68 ns production simulation with frames rendered every 150 ps.
For clarity of viewing, the peptide backbones in each configuration have been mutually aligned to a single reference configuration and water molecules removed. The peptide backbone is colored in red and the side chains in grey. This movie was produced using VMD (14) .
Movie S2. A 360° rotation around a representative peptide configuration. For clarity of viewing, the water molecules have been removed and the backbone and side chains colored in red and grey, respectively. This movie was produced using VMD (14) .
Movie S3. Fly-around of the 3D probability distribution of the side chain N12 atoms S30 around the α-helical backbone. Histograms were compiled over the simulation trajectory using a grid comprising cubic cells of size 0.1×0.1×0.1 nm, and the probability density function computed by normalizing by the total count and the cell volume. The value of the probability density in any one cell ranged from 0-3.7 nm -3 . Four contours in the probability density are plotted at 0.05, 0.1, 0.2, and 0.3 nm -3 . Since the positive charge in the cationic side chains resides primarily in the termini, this distribution may be considered a proxy for that of the positive charge. This movie was produced using MATLAB (15) .
